Results 161 to 170 of about 9,263,948 (394)

Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease [PDF]

open access: bronze, 2000
Silvia Montoto   +10 more
openalex   +1 more source

Hodgkin Disease and the Role of the Immune System

open access: yesPediatric Hematology & Oncology, 2011
A. Kennedy-Nasser, P. Hanley, C. Bollard
semanticscholar   +1 more source

Reproductive adverse events in patients with non‐Hodgkin lymphoma treated with chemotherapeutic regimens including cyclophosphamide, doxorubicin, vincristine, prednisone or CHOP with rituximab: A systematic review and meta‐analysis

open access: yesPediatric Discovery, EarlyView.
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL). Nine articles involving 331 patients were included in the meta‐analysis, the pooled proportion of reproductive adverse events was 22.3% (95% CI 11.4%–33.2%; p < 0.001). The findings
Rong Han   +6 more
wiley   +1 more source

Help from the past to cope with the future: Vitis sylvestris as a resource for abiotic stress resilience

open access: yesPLANTS, PEOPLE, PLANET, EarlyView.
Viticulture is facing increasing challenges due to climate change. The focus on fast growth and sweet berries has come at the expense of stress resilience. Grafting onto Phylloxera‐resistant rootstocks from American species has been the most successful form of ecological pest management.
Samia Daldoul   +6 more
wiley   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre   +5 more
wiley   +1 more source

Bilateral Periareolar Nodules in an Adolescent With a History of Lymphoma

open access: yes
JEADV Clinical Practice, EarlyView.
Rawan Almutairi   +5 more
wiley   +1 more source

A Multiple‐Model‐Informed Drug‐Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 572-582, March 2025.
ABSTRACT The antitumor efficacy of an intratumoral injection of a genetically engineered oncolytic vaccinia virus carrying human IL‐7 and murine IL‐12 genes (hIL‐7/mIL‐12‐VV) was demonstrated in CT26.WT‐bearing mice. In the CT26.WT‐bearing mouse model, the efficacy of the combination of hIL‐7/mIL‐12‐VV plus the anti‐programmed cell death protein (PD)‐1
Akihiro Yamada   +13 more
wiley   +1 more source

Granulomatous Lymphangitis Masquerading as Relapsed Hodgkin Disease on FDG PET/CT. [PDF]

open access: yesTomography, 2018
Mustafa M   +4 more
europepmc   +1 more source

Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances [PDF]

open access: bronze, 2001
Sabine Franke   +6 more
openalex   +1 more source

Mantle Cell Lymphoma of the Thyroid: A Rare Cause of Life‐Threatening Airway Compromise

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Kanokwan Kesornpatumanant   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy